http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012232948-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8c1ab8967271cf125eaf26889f2b8419 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_21a837b6e77981109aa7871f1ca8c2fa |
classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21 |
filingDate | 2011-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8774f60467325d98b20507d2752a205a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d4ff636e94c262e47139204942008b6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b76c8aafea44a6b8db7e0270364a9a9e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc5683b499690db94d47b4815a0e60bd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e04df4214db7d8652f67b92d0f441f8a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_acda12dcef88ed1c8c861ae54ba8f1bf |
publicationDate | 2012-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-2012232948-A |
titleOfInvention | Anti-morphine antibody, morphine measurement method using anti-morphine antibody, and morphine measurement kit including anti-morphine antibody |
abstract | To provide an excellent anti-morphine antibody that specifically recognizes morphine and has a low ability to recognize heroin, codeine, cocaine, and ketamine, and facilitates measurement of morphine in a sample. An anti-morphine antibody molecule comprising a heavy chain variable region and a light chain variable region that specifically recognizes morphine and has a low ability to recognize heroin, codeine, cocaine, and ketamine. Selected from the group consisting of antibodies (scFv), Fab fragments, F (ab ′) 2 fragments, Fv fragments, and complete antibodies, and in the heavy chain variable region, a) arranged as CDR-H1 The amino acid sequence described from position 31 to position 35 of SEQ ID NO: 1 in the sequence table, b) the amino acid sequence described from position 50 to position 65 of SEQ ID NO: 1 as CDR-H2, and c) 98 of SEQ ID NO: 1 as CDR-H3 And / or in the light chain variable region, a) the amino acid sequence described from position 160 to position 174 of SEQ ID NO: 1 in the sequence listing as the CDR-L1, b) CDR -L2 is position 190 in SEQ ID NO: 1 Amino acid sequence described in 196, and c) has the amino acid sequence of 237-position from the position 229 of SEQ ID NO: 1 as a CDR-L3, preparing an anti-morphine antibody. [Selection figure] None |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2702002-C1 |
priorityDate | 2011-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 914.